Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...

BTIG notes that shares of Tempus AI (TEM) are up on news that the company signed a $200M expanded strategic agreement with AstraZeneca (AZN) ...

Tempus AI shares were 14% higher, at $49.35, after the company said it has entered into multi-year strategic collaborations with AstraZeneca and Pathos AI.

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Whether you’re a recent graduate, a mid-career professional seeking a change, or an executive looking to enhance leadership skills, a career coach can be an invaluable resource. A 2021 Harris ...

Artificial intelligence (AI) is rapidly being integrated into every domain of healthcare, giving birth to a new class of tech-driven innovators. Tempus AI TEM and Doximity DOCS stand out as ...

On Thursday, Cathie Wood-led Ark Invest made notable trades, prominently featuring Tempus AI and Coinbase Global. The trades came as Wall Street reversed Wednesday's rally with a sharp selloff ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has earned an average rating of “Moderate Buy” from the twelve ratings firms that are currently covering the firm, Marketbeat.com reports.